Art

J-GLOBAL ID：201802258511807643   Reference number：18A0471394

Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose-finding phase

局所進行上顎洞癌(日本臨床腫瘍研究グループ1212)のためのシスプラチンと併用放射線療法の超選択的動脈内注入の用量と有効性確認試験:用量相【Powered by NICT】

Author (15)： Homma Akihiro (Department of Otolaryngology - Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan) ,  Onimaru Rikiya (Department of Radiation Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Matsuura Kazuto (Division of Head and Neck Surgery, Miyagi Cancer Center, Sendai, Japan) ,  Shinomiya Hirotaka (Department of Otolaryngology - Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Sakashita Tomohiro (Department of Otolaryngology - Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan) ,  Shiga Kiyoto (Department of Head and Neck Surgery, Iwate Medical University School of Medicine, Morioka, Japan) ,  Tachibana Hiroyuki (Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Japan) ,  Nakamura Kenichi (Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center, Tokyo, Japan) ,  Mizusawa Junki (Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center, Tokyo, Japan) ,  Kitahara Hideaki (Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center, Tokyo, Japan) ,  Eba Junko (Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center, Tokyo, Japan) ,  Fukuda Haruhiko (Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center, Tokyo, Japan) ,  Fujii Masato (Department of Otolaryngology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan) ,  Fujii Masato (Department of Otolaryngology, Eiju General Hospital, Tokyo, Japan) ,  Hayashi Ryuichi (Division of Head and Neck Surgery, National Cancer Center Hospital East, Kashiwa, Japan)
Material： Head & Neck: Journal for the Sciences & Specialties of the Head and Neck
Volume： 40  Issue： 3  Page： 475-484  Publication year： 2018 
JST Material Number： W2592A  ISSN： 1043-3074  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： BACKGROUND: We are currently u...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0471394&from=J-GLOBAL&jstjournalNo=W2592A") }}

Thesaurus term： intraarterial administration ,  *maxillary sinus ,  *therapy ,  patient ,  squamous cell carcinoma ,  safety ,  *cisplatin ,  *radiotherapy ,  *artery ,  tolerability
Semi thesaurus term： 用量規制毒性 ,  超選択的動注化学療法 ,  高用量 ,  *動脈内注入 ,  *日本臨床腫瘍研究グループ , 【Automatic Indexing@JST】

Author keywords (5)： chemoradiotherapy ,  cisplatin ,  intra-arterial ,  maxillary sinus cancer ,  squamous cell carcinoma

JST classification (3)： Treatment for tumors in general  (GE03031L) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Tumors(=neoplasms)of ear,nose,pharynx and larynx  (GQ04000E)

Terms in the title (9)： 上顎洞癌 ,  日本臨床腫瘍研究グループ ,  シスプラチン ,  併用 ,  放射線療法 ,  動脈内注入 ,  用量 ,  有効性確認 ,  試験